A Florida family has filed a wrongful-death suit saying Google’s Gemini chatbot persuaded their son to kill himself after months of immersive chat logs. The complaint includes thousands of pages of transcripts.

Denver’s CirrusMD has been acquired by Quantum Health, merging its chat‑first physician model with Quantum’s navigation tools to form a 20M‑member platform.

A bequest of more than $25M will endow three C.L. Best chairs, seed an innovation fund and pay for a robotics-and-sensing suite at UC Davis’ Resnick Center.

Ginkgo Bioworks is pivoting from benches to sell AI‑powered lab robots and a cloud lab out of its Boston Seaport hub after years of losses. The company hopes automation will revive revenue.

ARPA‑H is directing new program money into Boston’s Investor Catalyst Hub — backing lymphatic therapies and tear‑based monitoring — even as state leaders press for clarity after a stop‑work notice.

Pivot Bio has moved its global headquarters to Minnetonka’s Carlson Towers, bringing a roughly $2 billion ag‑tech company closer to Midwestern corn growers.

Scripps researchers in La Jolla will lead NASA’s EDGE mission, using spaceborne lasers to produce dense 3‑D elevation maps that could sharpen flood and coastal planning.

IU researchers show that sampling the right water pools removes puzzling isotope mismatches and could sharpen drought and water‑use forecasts for crops and ecosystems.

Indiana Donor Network used an in‑house ex‑vivo lung perfusion system to rehabilitate lungs rejected elsewhere, enabling a transplant that saved a local man.

Hyundai-backed Supernal cut about 296 jobs and shrank to roughly 70–80 staff as it consolidates operations at its Irvine engineering hub.

The LCME has listed Howard University College of Medicine as "Full, on probation." The university says accreditation and students’ degrees remain valid while it submits required fixes.

A new ranking places Philadelphia among the nation’s top startup cities, and local funding data and university-led funds suggest investment is beginning to return. The result highlights Philly’s durability and lower costs for founders.

A Carrboro mother and UNC researchers are testing an enzyme therapy that aims to slow brain decline in children with Hunter syndrome.